NetworkPharma
NetworkPharma provides a number of valued services to individuals working in and around the global pharmaceutical and medical industries, including the KeywordPharma series of publications. Written by pharmaceutical industry specialists, these are designed to be authoritative, relevant, succinct and helpful to pharmaceutical industry executives in their day-to-day work and in their longer term career development.
Your filters
clear all
None selected
previous
| Global Market for Nanoscale Smart Materials (NWP00013) Piezoelectric, Thermoelectric & Self-RepairingThis report provides intelligence on market potential, current technology status and future trends in the area of nanotechnology and smart materials. The market constantly asks for better devices and materials.... | Feb 2010 | £500€592$778 |
| European CME Forum: First Annual Meeting (NWP00012) The European landscape for continuing medical education (CME) is diverse and complex. The absence of a common framework across the region has led to individual countries developing their own national... | Feb 2009 | £75€89$117 |
| Pharma Sales World 2007 (NWP00011) Advanced Sales Force Remodelling Strategies in a Multi-Channel EnvironmentThe current environment for pharmaceutical companies can seem a hostile one, with major declines in sales, industry reputation and customer knowledge. However, to tackle these challenges, pharmaceutical companies are developing... | Jan 2008 | £75€89$117 |
| Strategies and Solutions for Publication Planning and Execution Excellence (NWP00010) The reputation of the global pharmaceutical industry is currently suffering, and there is public mistrust of drug companies' publication practices. The industry can only eradicate this problem through increased transparency,... | Sep 2007 | £75€89$117 |
| Online Marketing and eDetailing Europe (NWP00009) The pharmaceutical industry's commercial strategy has long been dominated by the sales force. The combination of an over-reliance on traditional sales and marketing methodology and a naturally conservative industry mindset... | Jul 2007 | £75€89$117 |
| Pharma Marketing ROI (NWP00008) Caught in a tightening vice between declining new product introductions and accelerating patent erosion, the pharmaceutical industry has been cutting back spending across the board to improve profits. Conversely, marketing... | Jan 2007 | £75€89$117 |
| Reporting Adverse Events (NWP00007) These are challenging times for drug safety professionals. Much is to be done within the profession to gain and maintain public trust by improving drug safety, pharmacovigilance and risk management... | Sep 2006 | £75€89$117 |
| Patient Compliance Europe (NWP00006) Patient non-compliance is an expensive and widespread problem for the pharmaceutical industry. With rates of non-compliance sometimes as high as 70 per cent, drug companies are losing around $25 billion... | Aug 2006 | £75€89$117 |
| Accelerating Patient Recruitment in Clinical Trials (NWP00001) All pharmaceutical companies want to find cost savings. The industry conducts large numbers of clinical trials each year. Regulatory requirements, as well as other scientific and marketing needs, mean that... | Jul 2006 | £75€89$117 |
| Online Marketing and eDetailing (NWP00005) The question of whether physicians are using online technology can finally be laid to rest. Studies show that between 70% and 90% of European physicians use the internet on a... | Jul 2006 | £75€89$117 |
| Drug Safety for Marketed Drugs (NWP00002) Safety surveillance has much to offer as a powerful knowledge-based tool capable of defending company products in the marketplace while conducting its primary function of safeguarding public health. However, this... | Apr 2006 | £75€89$117 |
| Mobile and Wireless Sales Force Strategies (NWP00004) Mobile communication is emerging as a core part of the pharmaceutical sales process. Doctors are no longer strangers to technology, with devices such as PDAs (personal data assistants) playing a... | Apr 2006 | £75€89$117 |
| Marketing ROI for Pharma (NWP00003) The pharmaceutical landscape is volatile. Research and development costs are soaring, purchasing power is being vested in fewer parties and regulations on pharmaceutical promotion are being tightened. Companies are under... | Jan 2006 | £75€89$117 |
